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Fig. 1 – Age-adjusted cardiovascular mortality/100,000 in
various South Asian countries and USA: WHO Global Status
Report on Non-Communicable Diseases 2014.1South Asian nations are facing an epidemic of cardiovascular
disease (CVD). According to the World Health Organization
(WHO) this region has one of the highest cardiovascular
mortality rates in the world.1 Age-adjusted cardiovascular
mortality rates in countries of this region vary from a low of
179/100,000 in men and 153/100,000 among women in
Bangladesh to a high of 349/100,000 among men in India
and 294/100,000 in women in Pakistan (Fig. 1). These rates are
more than 2–3 times greater than in USA where rates are
170/100,000 in men and 108/100,000 in women. Global Burden
of Diseases Study has reported that deaths as well as disability
from ischemic heart disease (IHD) has more than quadrupled
in most of the countries of this region in the last 30 years.2 Four
factors contribute to high cardiovascular disease burden and
high mortality in this region3: (a) lack of policies related to
social determinants of cardiovascular diseases and control of
primordial risk factors (smoking, non-smoked tobacco, alco-
hol, physical inactivity and unhealthy diet) for IHD prevention;
(b) poor quality preventive management, i.e., poor control of
risk factors (smoking, obesity, high blood pressure, high
cholesterol, and diabetes); (c) low availability and quality of
acute IHD management; and (d) lack of appropriate long term
care of these patients and absent cardiovascular rehabilitative
and secondary prevention programs. Unfortunately, all these
factors are widely prevalent in South Asian countries. The
Prospective Urban Rural Epidemiology (PURE) Study reported
that despite lower overall cardiovascular risk in 4 low income
countries (represented by India, Pakistan and Bangladesh) and
a low INTERHEART risk score, CVD mortality was the highest
in these countries compared to 13 high-, middle- and lower-
middle income countries.4 This suggests that the levels of riskfactor control is low, acute disease management is poor and so
are secondary prevention practices.5
1. Coronary risk factors in Bangladesh
There are no prospective studies in this region that have
determined factors of risk for IHD. Risk factors for premature
IHD in this region have been quantiﬁed in the INTERHEART
study.6 In this case–control study, nine common risk factors
explained more than 90% of incident acute myocardial
infarctions in South Asian patients. The risk factors include
dyslipidemia (ApoB/ApoA1 ratio), smoking, hypertension,
diabetes, abdominal obesity, physical inactivity, low fruits
and vegetables in diet, alcohol abuse and psychosocial stress.6
All these risk factors are widely prevalent in South Asian
countries. Reviews from India, Bangladesh and Pakistan have
reported that all the major risk factors – especially cardiome-
tabolic risk factors– obesity, abdominal obesity, hypertension,
dyslipidemia, and diabetes are increasing.7–9 These reviews
are, however, based on small regional studies in urban, rural or
both populations and there is a need for nationally represen-
tative studies.
IHD is an important medical and public health problem in
Bangladesh and is a leading cause of mortality. Similar to other
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coronary disease which is often premature in onset, follows a
rapidly progressive course and is angiographically more
severe.10 The underlying pathophysiology is poorly under-
stood. Genetic predisposition, high prevalence of metabolic
syndrome and conventional risk factors play important role.
Lifestyle related factors, including poor dietary habits, excess
saturated and trans fat, high salt intake, and low-level physical
activity may be important. Some novel risk factors, including
hypovitaminosis D, arsenic contamination in water and food,
and particulate matter air pollution may play unique role.10
Bangladesh is a pioneer in estimation of national burden of
risk factors. Several efforts to estimate the burden of risk
factors have been undertaken. In 2002, a survey used World
Health Organization (WHO) stepwise approach to surveillance
(STEPS) methodology and reported that preventable risk
factors including tobacco use, unhealthy diets, physical
inactivity and alcohol abuse were becoming an increasing
problem in the country.11 Countrywide, evidence suggests that
there are high rates of any tobacco use – particularly among
men, moderate rates of low fruit and vegetable consumption
and high rates of physical inactivity among adults.8
In this issue of the journal, Zaman and co-authors present
data on cardiometabolic risk factors – diabetes and hypercho-
lesterolemia – from the second phase of WHO-STEPS in a
nationally representative population based study in
Bangladesh.12 Results indicate that there is a signiﬁcant
prevalence of diabetes at 5.5% (men 7.6%, women 2.8%) and
its prevalence is signiﬁcantly greater in urban (7.6%) compared
with rural (2.8%) populations. In this study diabetes has been
diagnosed by criteria of either previously diagnosed diabetes or
fasting glucose ≥126 mg/dl and this may be an under-reporting
of the condition as combining these criteria with use of 2-h post-
glucose load blood glucose shall increase this prevalence rate.
The study also evaluated the prevalence of hypercholesterol-
emia and reported a very low prevalence (1.3%) of severe
hypercholesterolemia (total cholesterol ≥240 mg/dl) as well as
borderline high total cholesterol (≥200 mg/dl) at 5.8%. Total
cholesterol ≥170 mg/dl corresponds to low density lipoprotein
(LDL) cholesterol >100 mg/dl, the currently accepted criteria of
cardiovascular risk, and it would have been helpful if the
authors had provided data at this level of risk. The mean
cholesterol level in the present study is 167  26 mg/dl and this
is greater than the population means of 156 mg/dl in a 1996
study in a Bangladeshi rural population and similar to recent
studies in Bangladesh.8 As there is a continuous and graded
relationship of total and LDL cholesterol with coronary risk,13 a
rightward shift of the total cholesterol bell-curve suggests a
signiﬁcant increase in coronary risk in Bangladesh.
2. Comparison with other South Asian
countries
How do these data compare with studies in India and Pakistan,
the other large countries of South Asian region? Although there
are no nationally representative studies about prevalence of
diabetes and hypercholesterolemia in these countries, reviews
have reported greater prevalence than in Bangladesh. Reviews
of studies from India have reported diabetes prevalence of 3–4%in rural adults and 8–12% in the urban.14 Similarly prevalence of
hypercholesterolemia (≥200 mg/dl) is about 20–25% in urban
adults and 10–12% in the rural.15 PODIS (Prevalence of diabetes
In India study), a nationwide study, evaluated diabetes
prevalence at multiple urban and rural sites in India using
clinical diagnosis and fasting blood glucose levels and reported
diabetes in 4.3%.16 The standardized prevalence of diabetes in
urban areas (5.9%) was signiﬁcantly higher than in rural
populations (2.7%). These rates are lower than the prevalence
in Bangladesh. However, the ICMR-INDIAB study has reported a
higher prevalence of diabetes in 4 Indian states ranging from
10.4% in Tamil Nadu, 8.4% in Maharashtra, 5.3% in Jharkhand
and 13.6% in Chandigarh.17 Pakistan Diabetes Survey reported
diabetes and impaired fasting glucose prevalence of 22.0% in
urban and 17.2% in rural areas and another study reported
diabetes in 12.1% men and 9.8% women in the Punjab province.9
There are no representative data on prevalence of hypercholes-
terolemia in Pakistan although Global Burden of Chronic
Diseases Risk Factors study reported that high total cholesterol
was responsible for about 100,000 deaths.9Greater prevalence of
diabetes and hypercholesterolemia has been reported form
other South Asian nations – Sri Lanka and Nepal.1 Another
limitation of the study by Zaman et al.12 is the measurement of
other lipid parameters that are important cardiovascular risk
factors in South Asians. These parameters include apolipopro-
teins, triglycerides, high-density lipoprotein (HDL) cholesterol
and non-HDL cholesterol.6 Large national studies such as India
Heart Watch in urban populations18 and Indian Industrial
Population Study19 have reported that these dyslipidemias are
present in signiﬁcant number of adults in India.
3. Conclusions
The study by Zaman et al. is an important addition to
epidemiology of cardiometabolic risk factors in the South
Asian region. The study uses standard WHO-STEPS method-
ology to assess national prevalence of diabetes and hypercho-
lesterolemia. This is a lesson in epidemiological methodology
for larger countries such as India and Pakistan where such
studies are non-existent. There is signiﬁcant presence of
diabetes and hypercholesterolemia in Bangladesh and al-
though these risk factors as well as cardiovascular mortality
are lower than in other South Asian countries (Fig. 1), it
points to an impending epidemic. Whether the fractured and
choked health systems of Bangladesh, India and Pakistan can
cope with this epidemic awaits future reports. Meanwhile,
Bangladesh with its inclusive health system,20 which has
successfully tackled problems of infections and maternal and
childhood diseases better than its neighbors, is poised to lead
the way forward. Thus, the present study12 suggests that
cardiovascular risk is widespread in the country, and although
at a lower level than in the neighboring countries, it is likely
that with social and epidemiological transition cardiovascular
diseases would emerge as important.
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